Purpose: To report a unique case of bilateral isolated inferior oblique muscle paralysis (IOP) causing torsional diplopia following facial botulinum toxin (BTX) injections. Case report: A 37-year-old female presented with acute-onset torsional diplopia, exacerbated in primary and upward gaze, and alleviated on downward gaze. Neurological evaluations, including cranial/orbital MRI and neostigmine testing, were negative. Ophthalmic examination demonstrated bilateral incyclotorsion, consistent with bilateral IOP. History revealed recent periocular BTX injections for infraorbital rhytids, and experienced post-injection dizziness that necessitated a 30-min recumbent position. Notably, diplopia risk was undisclosed during consent. Symptoms resolved spontaneously within a week and did not recur over three years.
Conclusion: This case emphasizes the need for careful injection practices, proper post - injection care, informed consent, and vigilance for atypical symptoms to prevent and manage BTX - related ophthalmic complications.
Von NoordenGKCamposEC. Binocular vision and ocular motility: theory and management of strabismus. 6th ed. St Louis: Mosby, 2002, 431, 63.
2.
NadeemS. Isolated inferior oblique pareses. Int Ophthalmol2022; 42: 3165–3181.
3.
CastroOJohnsonLNMamourianAC. Isolated inferior oblique paresis from brain-stem infarction: perspective on oculomotor fascicular organization in the ventral midbrain tegmentum. Arch Neurol1990; 47: 235–237.
4.
AlmogYBen-DavidMNemetAY. Inferior oblique muscle paresis as a sign of myasthenia gravis. J Clin Neurosci2016; 25: 50–53.
5.
WuXFYanJH. Diagnosis and surgical management of isolated inferior oblique palsy. Int J Ophthalmol2020; 13: 349–355.
6.
BorbaAMatayoshiSRodriguesM. Avoiding complications on the upper face treatment with botulinum toxin: a practical guide. Aesthetic Plast Surg2022; 46: 385–394.
7.
Galindo-FerreiroAFraile GarcíaMSchelliniS, et al.Objective assessment of tear film in blepharospasm, facial hemispam and aberrant regeneration with periocular botulinum toxin-A. Eur J Ophthalmol2025; 35: 722–726.
8.
SkorochodRNesherRNesherG, et al.Ophthalmic adverse events following facial injections of botulinum toxin A: a systemic literature review. J Cosmet Dermatol2021; 20: 2409–2413.
9.
SethiNSinghSDeBoulleK, et al.A review of complications due to the use of botulinum toxin A for cosmetic indications. Aesthetic Plast Surg2021; 45: 1210–1220.
10.
KothariMShukriNQuayyumA. Transient superior oblique paresis after injection of botulinum toxin A for facial rejuvenation. Indian J Ophthalmol2012; 60: 77–78.
11.
NarangPSinghSMittalV. Bilateral herpes simplex keratitis reactivation after lacrimal gland botulinum toxin injection. Indian J Ophthalmol2018; 66: 697–699. doi:10.4103/ijo.IJO_904_17
12.
WutthiphanSKowalLO’DayJ, et al.Diplopia following subcutaneous injections of botulinum A toxin for facial spasms. J Pediatr Ophthalmol Strabismus1997; 34: 229–234.
13.
SatriyasaBK. Botulinum toxin (Botox) A for reducing the appearance of facial wrinkles: a literature review of clinical use and pharmacological aspect. Clin Cosmet Investig Dermatol2019; 12: 223–228. doi:10.2147/CCID.S202919
14.
AristodemouPWattLBaldwinC, et al.Diplopia associated with the cosmetic use of botulinum toxin a for facial rejuvenation. Ophthalmic Plast Reconstr Surg2006; 22: 134–136.
